Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

232 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomised controlled trial of Antiglucocorticoid augmentation (metyrapone) of antiDepressants in Depression (ADD Study).
Ferrier IN, Anderson IM, Barnes J, Gallagher P, Grunze HCR, Haddad PM, House AO, Hughes T, Lloyd AJ, Mamasoula C, McColl E, Pearce S, Siddiqi N, Sinha B, Speed C, Steen N, Wainwright J, Watson S, Winter FH, McAllister-Williams RH; the ADD Study Team. Ferrier IN, et al. Southampton (UK): NIHR Journals Library; 2015 Jun. Southampton (UK): NIHR Journals Library; 2015 Jun. PMID: 26086063 Free Books & Documents. Review.
Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial.
McAllister-Williams RH, Anderson IM, Finkelmeyer A, Gallagher P, Grunze HC, Haddad PM, Hughes T, Lloyd AJ, Mamasoula C, McColl E, Pearce S, Siddiqi N, Sinha BN, Steen N, Wainwright J, Winter FH, Ferrier IN, Watson S; ADD Study Team. McAllister-Williams RH, et al. Among authors: ferrier in. Lancet Psychiatry. 2016 Feb;3(2):117-27. doi: 10.1016/S2215-0366(15)00436-8. Epub 2015 Dec 23. Lancet Psychiatry. 2016. PMID: 26727041 Clinical Trial.
Study protocol for the randomised controlled trial: antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study).
McAllister-Williams RH, Smith E, Anderson IM, Barnes J, Gallagher P, Grunze HC, Haddad PM, House AO, Hughes T, Lloyd AJ, McColl EM, Pearce SH, Siddiqi N, Sinha B, Speed C, Steen IN, Wainright J, Watson S, Winter FH, Ferrier IN. McAllister-Williams RH, et al. Among authors: ferrier in. BMC Psychiatry. 2013 Aug 3;13:205. doi: 10.1186/1471-244X-13-205. BMC Psychiatry. 2013. PMID: 23914988 Free PMC article. Clinical Trial.
Metyrapone in treatment-resistant depression.
Sigalas PD, Garg H, Watson S, McAllister-Williams RH, Ferrier IN. Sigalas PD, et al. Among authors: ferrier in. Ther Adv Psychopharmacol. 2012 Aug;2(4):139-49. doi: 10.1177/2045125312436597. Ther Adv Psychopharmacol. 2012. PMID: 23983967 Free PMC article.
232 results